$Gain Therapeutics (GANX.US)$Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson's Disease 2 MINUTES AGO, 7:30 AM EDT VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
annna : short attack
Trytosaveabit OP annna : True! Plus it’s phase 1 so not sure until market open what kinda interest is really there? GL
let it squeeze Trytosaveabit OP : I'm wondering if shorts went a little premature? grabbed the dip and will see what happens...I'm interested.
Trytosaveabit OP let it squeeze : I’m definitely watching